Robo Co-op Partners with AVPN as Japan Market Strategic Partner for USD 15-Million AI Opportunity Fund: Asia-Pacific Initiative (First Phase), Supported by Google.org and ADB
TOKYO, June 2, 2025 /PRNewswire/ -- Robo Co-op, a refugee-led cooperative devoted to promoting digital inclusion, is pleased to announce its participation as a Strategic Partner of the first phase of AI Opportunity Fund: Asia-Pacific, AVPN's USD 15...
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for...
Dilon Technologies Partners with Australian Allografts as Exclusive Distributor for Navigator 2.0™ Gamma Localization System in Australia
NEWPORT NEWS, Va., June 2, 2025 /PRNewswire/ -- Dilon Technologies is pleased to announce the partnership of Australian Allografts as the exclusive distributor of the Navigator 2.0™ Lymphatic Mapping System in Australia, effective immediately. This...
Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture
CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Merieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality, New Zealand's premier food assurance provider, are pleased to announce the official...
NBA CHINA AND AMBER AVIATION ANNOUNCE FAN ENGAGEMENT COLLABORATION
- Collaboration Makes Amber Aviation the Official Private Jet Partner of NBA China - HONG KONG, May 30, 2025 /PRNewswire/ -- NBA China and Amber Aviation Limited, one of Asia-Pacific's fastest-growing private jet operators, today announced a...
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA
SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[ 1] SINGAPORE, May 30, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised...
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with...
Vantage Takes Home "Best Customer Support" at Global Business Review Magazine Awards 2025
PORT VILA, Vanuatu, May 29, 2025 /PRNewswire/ -- Vantage Markets is proud to announce its recognition as the winner of "Best Customer Support" at the prestigious Global Business Review Magazine Awards 2025. This accolade highlights Vantage's...
TraumaConnect®: A New Digital Lifeline for Australians Living with Trauma—and the Professionals Who Support Them
MELBOURNE, Australia, May 29, 2025 /PRNewswire/ -- The Cairnmillar Institute is proud to announce the launch of TraumaConnect® , a groundbreaking digital mental health platform designed to support Australians affected by trauma—while also empowering...
Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain
TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for...